13430.00HUFMkt Cap: 13.19T HUFP/E: —Last update: 2026-05-12
Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates thro…
Industry Peers
Drug Manufacturers - Generalloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG4.66
P/B457.41
P/S291.63
EV/EBITDA1302.05
EV/Revenue292.34
EPS (TTM)-785.66
EPS (Forward)—
Cash Flow & Leverage
FCF Yield0.06%
FCF Margin16.17%
Operating CF5.93B HUF
CapEx (TTM)2.49B HUF
Net Debt/EBITDA3.17
Net Debt32.23B HUF
Technical
SMA 5014610.66 (-8.1%)
SMA 20013274.97 (+1.2%)
Beta0.84
S&P 52W Chg24.23%
Avg Vol (30d)100
Avg Vol (10d)55
Technical Indicators
RSI (14)34.2
MACD-467.9082
MACD Signal-440.2029
MACD Hist.-27.7052
BB Upper15485.54 HUF
BB Middle14050.25 HUF
BB Lower12614.96 HUF
BB Width20.43%
ATR (14)190.02 HUF
Vol Ratio (20d)0.00x
52W Range
—
52W High13430.00 HUF
52W Low13430.00 HUF
Profitability
Gross Margin58.76%
EBITDA Margin22.45%
Profit Margin-7.94%
Oper. Margin26.32%
ROE-13.95%
ROA-3.46%
Revenue Growth-2.40%
Earnings Growth112.90%
Balance Sheet
Debt/Equity1.40
Current Ratio1.05
Quick Ratio0.69
Book Value/Sh29.36 HUF
Cash/Share6.779 HUF
Dividends
Fwd Div Rate40.04 HUF
Trail. Div Rate0.1100 HUF
Div. Yield0.30%
5Y Avg Yield—
Payout Ratio163.27%
Ex-Div DateApr 27, 2026
Pay Date—
Ownership
Shares Out.982.42M
Float982.42M
Insiders0.00%
Institutions56.80%
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Company
Market Cap13.19T HUF
Enterprise Value13.23T HUF
Revenue (TTM)45.24B HUF
Gross Profit26.78B HUF
Net Income (TTM)-3.62B HUF
Revenue/Share46.05 HUF
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees87.8K
Last Price13430.00 HUF
CountryHU
SectorHealthcare
IndustryDrug Manufacturers - General
ISIN—